PECULIARITIES OF ANTIHYPERTENSIVE THERAPY INDICATED IN THERAPEUTIC AND SURGICAL DEPARTMENTS OF THE UNIVERSITY CLINICAL HOSPITAL

PECULIARITIES OF ANTIHYPERTENSIVE THERAPY INDICATED IN THERAPEUTIC AND SURGICAL DEPARTMENTS OF THE UNIVERSITY CLINICAL HOSPITAL

Treatment of arterial hypertension (AH) despite the large variety of antihypertensive drugs currently remains one of the most urgent problems in modern cardiology. However, the scheme used in clinical practice does not always correspond to existing recommendations, in particular, of the European Soc...

書誌詳細
主要な著者:	N. A. Morina, O. D. Savkova, E. A. Fedorova, I. L. Tsarev, A. B. Frolkova, A. E. Tsygankova, A. A. Sokolova, D. A. Napalkov, V. V. Fomin
フォーマット:	論文
言語:	Russian
出版事項:	Remedium Group LLC 2017-11-01
シリーズ:	Медицинский совет
主題:	arterial hypertension cardiovascular complications antihypertensive therapy angiotensin converting enzyme inhibitors renin-angiotensin-aldosterone system blockers slow calcium channel blockers
オンライン･アクセス:	https://www.med-sovet.pro/jour/article/view/2007

類似資料

Influence of Antihypertensive Treatment on RAAS Peptides in Newly Diagnosed Hypertensive Patients
著者:: Annina S. Vischer, 等
出版事項: (2021-03-01)

Role of antihypertensive medicines in prostate cancer: a systematic review
著者:: Chinonyerem O. Iheanacho, 等
出版事項: (2024-04-01)

Blood Pressure Control and Antihypertensive Treatment among Hemodialysis Patients—Retrospective Single Center Experience
著者:: Piotr Skonieczny, 等
出版事項: (2021-06-01)

Effect of antihypertensive drugs on breast cancer risk in female hypertensive patients: Evidence from observational studies
著者:: Yang Zhao, 等
出版事項: (2018-01-01)

Mechanisms of food protein-derived antihypertensive peptides other than ACE inhibition
著者:: Chibuike C. Udenigwe, 等
出版事項: (2014-05-01)

Prescription pattern and effectiveness of antihypertensive drugs in patients with aortic dissection who underwent surgery
著者:: Kuang-Ming Liao, 等
出版事項: (2023-11-01)

Renin-angiotensin-aldosterone system blockers as the main pathogenetic approach of drug nephroprotection
著者:: N.D. Filipets, 等
出版事項: (2019-02-01)

Renin‐Angiotensin Aldosterone System Inhibitors and COVID‐19: A Systematic Review and Meta‐Analysis Revealing Critical Bias Across a Body of Observational Research
著者:: Jordan Loader, 等
出版事項: (2022-06-01)

Controversial Roles of the Renin Angiotensin System and Its Modulators During the COVID-19 Pandemic
著者:: Simon B. Gressens, 等
出版事項: (2021-02-01)

Renin-angiotensin system blockers and COVID-19
著者:: Emmanuelle Vidal-Petiot, 等
出版事項: (2021-06-01)

Angiotensins and rheumatoid arthritis
著者:: N. M. Savushkina, 等
出版事項: (2019-01-01)

Association between types of antihypertensive medication and the risk of atrial fibrillation: a nationwide population study
著者:: JungMin Choi, 等
出版事項: (2024-05-01)

Association of Cardiovascular Medications With Adverse Outcomes in a Matched Analysis of a National Cohort of Patients With COVID-19
著者:: Leonard K. Wang, 等
出版事項: (2023-06-01)

Assessment of Anti-Hypertensive Drug Adherence by Serial Aldosterone-To-Renin Ratio Measurement
著者:: Fabrizio Buffolo, 等
出版事項: (2021-05-01)

Prospects of using genetic testing to increase the effectiveness of antihypertensive therapy
著者:: N. V. Drobotya, 等
出版事項: (2020-06-01)

Effect of different single and combined antihypertensive drug regimens on the mortality of critical care patients
著者:: Yipeng Fang, 等
出版事項: (2024-08-01)

Research Progress on Antihypertensive Effect of Polysaccharide and Its Mechanism
著者:: Jilong XU, 等
出版事項: (2023-02-01)

Antihypertensive therapy in patients with arterial hypertension and concomitant diseases in real clinical practice (according to the National Registry of Arterial Hypertension, 2019–2022)
著者:: Anna V. Aksenova, 等
出版事項: (2024-10-01)

INACTIVATION OF RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM. WHICH CLASS OF ANTIHYPERTENSIVE MEDICINE PRODUCTS TO PREFER?
著者:: S. V. Stolov
出版事項: (2020-12-01)

Effect of antihypertensive treatment on the long-term outcome of patients discharged after acute ischemic stroke
著者:: Konstantinos Tziomalos, 等
出版事項: (2017-04-01)

Sartans in the treatment of high-risk hypertension: the abilities of candesartan
著者:: T E Morozova
出版事項: (2013-06-01)

ACE INHIBITORS AND ANGIOTENSIN II RECEPTOR BLOCKERS IN THE TREATMENT OF CARDIOVASCULAR DISEASE: WHAT TO CHOOSE?
著者:: K. A. Ghyamdzhyan, 等
出版事項: (2022-12-01)

The renin–angiotensin–aldosterone-system and right heart failure in congenital heart disease
著者:: Stine Andersen, 等
出版事項: (2016-06-01)

Effect of ACEi and ARBs vs Non ACEi/ARBs in Hypertension with Respect to Renal Outcomes in COVID-19 Infection: A Retrospective Cohort Study
著者:: S Ravitej, 等
出版事項: (2022-11-01)

Assessment of optimal renin-angiotensin-system inhibition strategy in Asian patients with STEMI after primary myocardial revascularization
著者:: Hye-Jin Park, 等
出版事項: (2022-01-01)

Perspectives of using angiotensin receptor antagonists
著者:: V V Fomin
出版事項: (2009-06-01)

Initial Antihypertensive Regimens in Newly Treated Patients: Real World Evidence From the OneFlorida+ Clinical Research Network
著者:: Steven M. Smith, 等
出版事項: (2023-01-01)

Hypertension, medications, and risk of severe COVID‐19: A Massachusetts community‐based observational study
著者:: Ann Z. Bauer, 等
出版事項: (2021-01-01)

Early Rapid Decline in Kidney Function as a Beneficial Sign After Starting Antihypertensive Medication
著者:: Joachim Beige
出版事項: (2019-06-01)

The Use of Antihypertensive Drugs as Coadjuvant Therapy in Cancer
著者:: José A. Carlos-Escalante, 等
出版事項: (2021-05-01)

Angiotensin receptor blocker telmisartan: efficacy, safety and relevance of clinical application
著者:: Maksimov M.L., 等
出版事項: (2017-02-01)

Angiotensin receptor blocker telmisartan: efficacy, safety and relevance of clinical application
著者:: M L Maksimov, 等
出版事項: (2017-03-01)

Clinical pharmacogenetics of angiotensin II receptor blockers in Iraq
著者:: Hany A Al-Hussaniy, 等
出版事項: (2023-01-01)

A Study of Morphological Changes in Renal Afferent Arterioles Induced by Angiotensin II Type 1 Receptor Blockers in Hypertensive Patients
著者:: Yohko Nagai, 等
出版事項: (2020-01-01)

Capacities of laboratory diagnosis in the assessment of the activity of the renin-angiotensin-aldosterone system
著者:: M L Maksimov
出版事項: (2010-06-01)

The Evolving Role of Calcium Channel Blockers in Hypertension Management: Pharmacological and Clinical Considerations
著者:: Kamryn E. Jones, 等
出版事項: (2024-06-01)

Final results of BIRCOV trial (ARB, ACEI, DRi in COVID-19)
著者:: D.D. Ivanov, 等
出版事項: (2021-09-01)

Dataset for discovering new hypertension small molecules using machine learning-aided computational fragment-based design
著者:: Odifentse Mapula-e Lehasa, 等
出版事項: (2024-08-01)

Resistance to antihypertensive drugs targeting Renin-Angiotensin-Aldosterone-System in cancer patients: a case series
著者:: Mishita Goel, 等
出版事項: (2020-08-01)

Renin-angiotensin-aldosterone system in climacteric women with arterial hypertension. Antihypertensive therapy features
著者:: A. E. Bragina, 等
出版事項: (2005-12-01)